Author

Supriya Mandal

Indian Council of Medical ResearchPrimary ORCID profile (0009-0006-4359-535X · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Supriya MandaliD1 paper · Meghnad Saha Institute of Technology

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

Arindam Mukherjee· 2 shared Ashis Debnath· 2 shared Asish K. MukhopadhyayiD· 2 shared Debaki Ranjan HowladeriD· 2 shared Hemanta KoleyiD· 2 shared Nivedita RoyiD· 2 shared Prolay HalderiD· 2 shared Soumalya BanerjeeiD· 2 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Arindam Mukherjee

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Third generation cephalosporin-induced L-form transition in Shigella sonnei reveals a virulence-survival trade-off underlying persistent infection

Sanjib Das, Arindam Mukherjee, Prolay Halder, Soumalya Banerjee, Supriya Mandal, Nivedita Roy, Ashis Debnath, Sreejani Banerjee, Manjistha Manna, Upama Mandal, Jiro Mitobe, Jeffrey H. Withey, Asish K. Mukhopadhyay, Santasabuj Das, Debaki Ranjan Howlader, Hemanta Koley

This paper shows that Shigella sonnei can transition into L-forms in response to third-generation cephalosporins, gaining survival benefits but losing virulence, leading to persistent infections.

Microbiology Spectrum · Jun 22, 2026Peer-reviewedMicrobiology

Potential probiotic application of a novel commensal E. coli with antagonistic activity against different enteric pathogens

Prolay Halder, Sanjib Das, Soumalya Banerjee, Arindam Mukherjee, Supriya Mandal, Ashis Debnath, Nivedita Roy, Asish K. Mukhopadhyay, Debaki Ranjan Howlader, Hemanta Koley

This paper identifies a commensal E. coli strain with antimicrobial activity against enteric pathogens and demonstrates its prophylactic and therapeutic potential in murine models.

bioRxiv · Dec 3, 2025 · PreprintMicrobiology